Simplex Trading
CHRS icon

Simplex Trading’s Coherus Oncology CHRS Stock Holding History

Simplex Trading’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.9K Sell
10,000
-51,300
-84% -$91.1K ﹤0.01% 6897
2025
Q4 		$87K Sell
61,300
-1,400
-2% -$2.04K ﹤0.01% 5136
2025
Q3 		$102K Buy
62,700
+17,100
+38% +$19K ﹤0.01% 5724
2025
Q2 		$33K Sell
45,600
-31,400
-41% -$27.1K ﹤0.01% 6307
2025
Q1 		$62K Sell
77,000
-206,100
-73% -$237K ﹤0.01% 5553
2024
Q4 		$390K Buy
283,100
+254,900
+904% +$286K ﹤0.01% 3803
2024
Q3 		$29K Buy
28,200
+3,700
+15% +$5.07K ﹤0.01% 6370
2024
Q2 		$42K Sell
24,500
-25,800
-51% -$51.9K ﹤0.01% 6242
2024
Q1 		$120K Sell
50,300
-25,500
-34% -$62.8K ﹤0.01% 5402
2023
Q4 		$252K Buy
75,800
+23,100
+44% +$61.9K ﹤0.01% 4422
2023
Q3 		$197K Buy
52,700
+48,200
+1,071% +$223K ﹤0.01% 4372
2023
Q2 		$19K Sell
4,500
-11,600
-72% -$68.4K ﹤0.01% 6816
2023
Q1 		$110K Buy
+16,100
New +$125K ﹤0.01% 5043
2022
Q4 		– Sell
-400
Closed -$3K – 9304
2022
Q3 		$3K Hold
400
– – ﹤0.01% 9049
2022
Q2 		$2K Sell
400
-200
-33% -$1.74K ﹤0.01% 9310
2022
Q1 		$7K Sell
600
-2,000
-77% -$25.4K ﹤0.01% 9151
2021
Q4 		$41K Sell
2,600
-11,300
-81% -$198K ﹤0.01% 7491
2021
Q3 		$198K Hold
13,900
– – ﹤0.01% 5597
2021
Q2 		$192K Buy
+13,900
New +$197K ﹤0.01% 5739
2021
Q1 		– Sell
-307
Closed -$533K – 8924
2020
Q4 		$533K Buy
307
+288
+1,516% +$5.13K ﹤0.01% 3343
2020
Q3 		$34K Sell
19
-200
-91% -$3.72K ﹤0.01% 5954
2020
Q2 		$391K Buy
219
+117
+115% +$1.98K ﹤0.01% 3210
2020
Q1 		$165K Sell
102
-62
-38% -$1.15K ﹤0.01% 3811
2019
Q4 		$295K Sell
164
-82
-33% -$1.51K ﹤0.01% 3303
2019
Q3 		$498K Buy
246
+245
+24,500% +$4.89K ﹤0.01% 2630
2019
Q2 		$2K Sell
1
-27
-96% -$469 ﹤0.01% 6730
2019
Q1 		$38K Sell
28
-2
-7% -$27 ﹤0.01% 5222
2018
Q4 		$27K Buy
30
+29
+2,900% +$336 ﹤0.01% 5079
2018
Q3 		$1K Sell
1
-49
-98% -$869 ﹤0.01% 7171
2018
Q2 		$70K Buy
+50
New +$716 ﹤0.01% 4690
2018
Q1 		– Sell
-107
Closed -$2K – 6201
2017
Q4 		$2K Buy
107
+71
+197% +$760 ﹤0.01% 5136
2017
Q3 		$1K Sell
36
-107
-75% -$1.42K ﹤0.01% 5371
2017
Q2 		$5K Buy
143
+121
+550% +$2.33K ﹤0.01% 4559
2017
Q1 		$3K Buy
22
+9
+69% +$221 ﹤0.01% 4942
2016
Q4 		$1K Buy
+13
New +$364 ﹤0.01% 5328
2015
Q3 		– Sell
-10
Closed -$1K – 5553
2015
Q2 		$1K Buy
+10
New +$253 ﹤0.01% 4585

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

Simplex Trading's CHRS Position: Q1 2026 in Review

Simplex Trading reduced its Coherus Oncology (CHRS) stake by 7.6% in Q1 2026, selling an estimated $6.47K and leaving 44,402 shares worth $75K. The position accounts for ﹤0.01% of the portfolio, ranked #5412.

Simplex Trading first reported a position in CHRS in Q3 2015 and has held it in 40 quarters since. The position peaked at $1.03M in Q2 2019. 157 funds tracked by Wall St. Rank hold CHRS as of Q1 2026.

  • Simplex Trading held 44,402 shares of Coherus Oncology worth $75K as of Q1 2026.
  • Simplex Trading sold 3,642 Coherus Oncology shares in Q1 2026, an estimated $6.47K.
  • Coherus Oncology made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #5412 holding.
  • Simplex Trading first reported a position in Coherus Oncology in Q3 2015 and has held it in 40 quarters since.
  • Simplex Trading's Coherus Oncology position peaked at $1.03M in Q2 2019.
  • 157 funds tracked by Wall St. Rank held Coherus Oncology as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.